Sign In
Buy ILMN
$205.10
+0.0100 (+0.0049%)
At Close: Jul 31, 2026
Envestnet Asset Management Inc. Sells 8,180 Shares of Illumina, Inc. $ILMN
05:56am, Monday, 03'rd Nov 2025
Envestnet Asset Management Inc. trimmed its stake in Illumina, Inc. (NASDAQ: ILMN) by 2.6% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commissi
DNA Sequencing Firm Illumina Sees Strong Clinical Market Momentum, Stock Soars
12:01pm, Friday, 31'st Oct 2025
Illumina Inc. (NASDAQ:ILMN) stock is trading higher after the company reported better-than-expected third-quarter earnings.
Illumina, Inc. (ILMN) Q3 2025 Earnings Call Transcript
10:26pm, Thursday, 30'th Oct 2025
Illumina, Inc. ( ILMN ) Q3 2025 Earnings Call October 30, 2025 4:30 PM EDT Company Participants Conor Noel McNamara - VP of Investor Relations Jacob Thaysen - CEO & Director Ankur Dhingra - Chief Fina
Compared to Estimates, Illumina (ILMN) Q3 Earnings: A Look at Key Metrics
08:30pm, Thursday, 30'th Oct 2025
The headline numbers for Illumina (ILMN) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street est
Illumina (ILMN) Beats Q3 Earnings and Revenue Estimates
06:36pm, Thursday, 30'th Oct 2025
Illumina (ILMN) came out with quarterly earnings of $1.34 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.14 per share a year ago.
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025
04:05pm, Thursday, 30'th Oct 2025
Revenue of $1.08 billion for Q3 2025, flat compared to Q3 2024 on both a reported and constant currency basis GAAP operating margin of 21.0% and non-GAAP operating margin of 24.5% for Q3 2025 GAAP dil
Illumina, Inc. $ILMN Shares Sold by Stephens Inc. AR
04:08am, Sunday, 26'th Oct 2025
Stephens Inc. AR trimmed its stake in Illumina, Inc. (NASDAQ: ILMN) by 12.6% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission.
Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:00am, Thursday, 23'rd Oct 2025
Illumina (ILMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Illumina, Inc. (NASDAQ:ILMN) Receives Consensus Recommendation of “Hold” from Analysts
01:48am, Wednesday, 22'nd Oct 2025
Shares of Illumina, Inc. (NASDAQ: ILMN - Get Free Report) have been given an average rating of "Hold" by the nineteen brokerages that are covering the company, Marketbeat reports. Three equities resea
Illumina: Innovation Outweighs Short-Term Risks - A Long-Term Buy Ahead Of Q3 Earnings
02:16pm, Tuesday, 21'st Oct 2025
Illumina is at a pivotal moment, balancing near-term challenges with innovations in multiomics, AI, and proteomics to redefine its growth trajectory. ILMN's planned SomaLogic acquisition and new AI-dr
Final Trades: Illumina, Columbia Banking, Alibaba and JPMorgan Chase
04:21pm, Monday, 20'th Oct 2025
The Investment Committee give you their top stocks to watch for the second half.
KMDA or ILMN: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 15'th Oct 2025
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Kamada (KMDA) and Illumina (ILMN). But which of these two stocks is more attractive to value investo
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
09:15am, Wednesday, 15'th Oct 2025
Illumina's up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx Constellation outperformed orthogonal methods in identifying select difficult-to-map vari
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights
09:15am, Wednesday, 15'th Oct 2025
At ASHG, an early access customer from the London Health Sciences Center Research Institute will demonstrate the power of the 5-base genome for accelerating resolution of rare disease cases Proprietar
Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025
04:05pm, Tuesday, 14'th Oct 2025
SAN DIEGO , Oct. 14, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the third quarter 2025 following the close of market on Thursday, October 30, 202
